Bright Horizons, Remitly Join S&P SmallCap 600 as Apellis and Tri Pointe Exit
S&P Dow Jones Indices will add Bright Horizons Family Solutions and Remitly Global to the S&P SmallCap 600 effective May 14, replacing Tri Pointe Homes and Apellis Pharmaceuticals. Biogen’s acquisition of Apellis Pharmaceuticals, expected to close pending final conditions, prompted Apellis’s deletion from the index.
1. S&P SmallCap 600 Rebalance
S&P Dow Jones Indices will add Bright Horizons Family Solutions and Remitly Global to the S&P SmallCap 600 ahead of trading on May 14, removing Tri Pointe Homes and Apellis Pharmaceuticals. These changes reflect market capitalization shifts and corporate transactions affecting index eligibility.
2. Biogen’s Acquisition of Apellis Pharmaceuticals
Biogen is acquiring Apellis Pharmaceuticals in a deal expected to close pending final conditions, triggering Apellis’s deletion from the S&P SmallCap 600. The transaction underscores Biogen’s strategy to expand its product pipeline and could reshape its revenue profile once finalized.